firategrast - CISMeF

Preferred Label : firategrast;

MeSH note : an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist designed to reduce trafficking of lymphocytes into the central nervous system;

MeSH Hyperonym : (1,1'-biphenyl)-4-propanoic acid, .alpha.-((2,6-difluorobenzoyl)amino)-4'(ethoxymethyl)-2',6'-dimethoxy-,(.alpha.S)-;

MeSH hyponym : SB-683699; SB683699;

UNII : OJY3SK9H5F;

Détails

Origin ID

C585685;

UMLS CUI

C2700183;

Currated CISMeF NLP mapping
- Firategrast [NCIt concept]
MeSH indexing information
- anti-inflammatory agents [MeSH Descriptor]
MeSH term(s) associated for indexing
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- (2S)-2-((2,6- difluorobenzoyl)amino)-3-(4'-(ethoxymethyl)-2',6'-dimethoxybiphenyl-4- yl)propanoic acid [MeSH concept]
- SB-683699 [MeSH concept]
- firategrast [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Firategrast [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients